Selarid: Product Information
SELARID- selamectin solution
Norbrook Laboratories Limited
Topical Parasiticide For Dogs and Cats
US Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Selarid (selamectin) Topical Parasiticide is available as a colorless to yellow, ready to use solution in single dose applicators for topical (dermal) treatment of dogs six weeks of age and older and cats eight weeks of age and older. The content of each applicator is formulated to provide a minimum of 2.7 mg/lb (6 mg/kg) of body weight of selamectin. The chemical composition of selamectin is (5Z,25S)-25-cyclohexyl-4′-O -de(2,6-dideoxy-3-O -methyl-α-L-arabino -hexopyranosyl) -5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-hydroxyiminoavermectin A1a .
Selarid is recommended for use in dogs six weeks of age or older and cats eight weeks of age and older for the following parasites and indications:
Selarid kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis , and the treatment and control of ear mite (Otodectes cynotis) infestations. Selarid also is indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
Selarid kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis , and the treatment and control of ear mite (Otodectes cynotis) infestations. Selarid is also indicated for the treatment and control of roundworm (Toxocara ca ti) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
Not for human use. Keep out of the reach of children.
In humans, Selarid may be irritating to skin and eyes. Reactions such as hives, itching and skin redness have been reported in humans in rare instances. Individuals with known hypersensitivity to Selarid should use the product with caution or consult a health care professional. Selarid contains isopropyl alcohol and the preservative butylated hydroxytoluene (BHT). Wash hands after use and wash off any product in contact with the skin immediately with soap and water. If contact with eyes occurs, then flush eyes copiously with water. In case of ingestion by a human, contact a physician immediately. The safety data sheet (SDS) provides more detailed occupational safety information. For a copy of the SDS or to report adverse reactions attributable to exposure to this product, call 1-866-591-5777.
Flammable — Keep away from heat, sparks, open flames or other sources of ignition.
Do not use in sick, debilitated or underweight animals (see SAFETY).
Prior to administration of Selarid, dogs should be tested for existing heartworm infections. At the discretion of the veterinarian, infected dogs should be treated to remove adult heartworms. Selarid is not effective against adult D. immitis and, while the number of circulating microfilariae may decrease following treatment, Selarid is not effective for microfilariae clearance.
Hypersensitivity reactions have not been observed in dogs with patent heartworm infections administered three times the recommended dose of selamectin solution. Higher doses were not tested.
Pre-approval clinical trials:
Following treatment with selamection solution, transient localized alopecia with or without inflammation at or near the site of application was observed in approximately 1% of 691 treated cats. Other signs observed rarely (≤0.5% of 1743 treated cats and dogs) included vomiting, loose stool or diarrhea with or without blood, anorexia, lethargy, salivation, tachypnea, and muscle tremors.
In addition to the aforementioned clinical signs that were reported in pre-approval clinical trials, there have been reports of pruritus, urticaria, erythema, ataxia, fever, and rare reports of death. There have also been rare reports of seizures in dogs (see WARNINGS).
The recommended minimum dose is 2.7 mg selamectin per pound (6 mg/kg) of body weight.
Administer the entire contents of a single dose applicator (or two applicators used in combination for dogs weighing over 130 pounds) of
Selarid topically in accordance with the following tables. (See ADMINISTRATION for the recommended treatment intervals.)
|Cats (lb)||Package color||mg per applicator||Potency (mg/mL)||Administered volume (mL)|
|Up to 5||Mauve||15 mg||60||0.25|
|5.1 – 15||Blue||45 mg||60||0.75|
|15.1 — 22||Taupe||60 mg||60||1.0|
For cats over 22 lbs use the appropriate combination of applicators
|Dogs (lb)||Package color||mg per applicator||Potency (mg/mL)||Administered volume (mL)|
|Up to 5||Mauve||15 mg||60||0.25|
|5.1 – 10||Purple||30 mg||120||0.25|
|10.1 – 20||Brown||60 mg||120||0.5|
|20.1 – 40||Red||120 mg||120||1.0|
|40.1 – 85||Teal||240 mg||120||2.0|
|85.1 — 130||Plum||360 mg||120||3.0|
For dogs over 130 lbs use the appropriate combination of applicators. Recommended for use in dogs 6 weeks of age and older and in cats 8 weeks of age and older.
VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.